跳至主要内容
临床试验/IRCT20160625028622N2
IRCT20160625028622N2招募中2 期

The effectiveness of dietary supplements containing antioxidant compounds on survival rate of patients with COVID-19

Qazvin University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 70 years(—)
性别
All

入选标准

  • A positive PCR test for a new coronavirus
  • Having an involvement in a CT scan of the lungs and a definitive diagnosis by the treating physician that the person is infected
  • Therefore, people whose confirmed results of this virus are confirmed and who have 2 or more of the following symptoms will be studied in the following study: Including: Patients with pulmonary involvement of 50% and above (severe cases) (sometimes closed At the discretion of the physician and the patient's condition, lower lung involvement is also a criterion for hospitalization (moderate cases), 90 <O2 saturation <94 (moderate to severe cases) and o2 saturation <90 (severe cases), sub-cough symptoms (visual assessment criteria) Sore throat (patient report), headache (patient report), nasal congestion (patient report), fever (temperature above 37.3), body aches and pains (patient report), fatigue (patient report)

排除标准

  • Patients suspected of having a bacterial respiratory infection at the beginning of the study
  • Patients with serious chronic diseases.
  • Pregnant women
  • Patients with HIV
  • Patients with cancer
  • Patients with vascular disease
  • Patient with endocrine disease
  • Patients who become infected during studying

研究者

相似试验